Continuing our studies on polyamine-based compounds of potential interest in the field of Alzheimer’s disease therapeutics, we investigated the structure-activity relationships (SAR) of a lead compound (caproctamine, 3) identified in a previous work. In particular, we varied the substituents on the phenyl ring and on the nitrogen functions (both the amine and the amide), and studied the effects of such modifications on the inhibitory potency against isolated acetyl- and butyryl cholinesterase (AChE and BChE). Moreover, the ability of selected compounds to reverse the D-tubocurarine-induced neuromuscular blockade and their antagonism toward muscarinic M2 receptors in guinea pig left atrium were assayed. The most interesting SAR result was the identification of a relationship between the electronic characteristics of 2-substituents (measured by pKa) and the AChE inhibitory potency (pIC50) of tertiary amine compounds 6-12, which was confirmed by the invariance of the pIC50 values of the corresponding methiodide derivatives 14-20. With regard to the biological profile, the most interesting compound was the N-ethyl-analogue of caproctamine (9), that showed pIC50 values of 7.73 ((0.02) and 5.65 ((0.03) against AChE and BChE, respectively. The ability to increase the acetylcholine level was maintained in the functional assay (pAI 50 for reversing the neuromuscular blockade was 6.45 ((0.07)), as well as the ability to antagonize the M2 receptors (pKb ) 5.65 ((0.06)). Moreover, 9 showed a long duration of action as AChE inhibitor, an useful property in view of a possible development of this compound as a therapeutic agent.

Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine

MARUCCI, Gabriella;ANGELI, Piero;
2003-01-01

Abstract

Continuing our studies on polyamine-based compounds of potential interest in the field of Alzheimer’s disease therapeutics, we investigated the structure-activity relationships (SAR) of a lead compound (caproctamine, 3) identified in a previous work. In particular, we varied the substituents on the phenyl ring and on the nitrogen functions (both the amine and the amide), and studied the effects of such modifications on the inhibitory potency against isolated acetyl- and butyryl cholinesterase (AChE and BChE). Moreover, the ability of selected compounds to reverse the D-tubocurarine-induced neuromuscular blockade and their antagonism toward muscarinic M2 receptors in guinea pig left atrium were assayed. The most interesting SAR result was the identification of a relationship between the electronic characteristics of 2-substituents (measured by pKa) and the AChE inhibitory potency (pIC50) of tertiary amine compounds 6-12, which was confirmed by the invariance of the pIC50 values of the corresponding methiodide derivatives 14-20. With regard to the biological profile, the most interesting compound was the N-ethyl-analogue of caproctamine (9), that showed pIC50 values of 7.73 ((0.02) and 5.65 ((0.03) against AChE and BChE, respectively. The ability to increase the acetylcholine level was maintained in the functional assay (pAI 50 for reversing the neuromuscular blockade was 6.45 ((0.07)), as well as the ability to antagonize the M2 receptors (pKb ) 5.65 ((0.06)). Moreover, 9 showed a long duration of action as AChE inhibitor, an useful property in view of a possible development of this compound as a therapeutic agent.
2003
262
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/112716
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 37
social impact